These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25472447)

  • 1. A new family of choline kinase inhibitors with antiproliferative and antitumor activity derived from natural products.
    Estévez-Braun A; Ravelo AG; Pérez-Sacau E; Lacal JC
    Clin Transl Oncol; 2015 Jan; 17(1):74-84. PubMed ID: 25472447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical characterization of RSM-932A, a novel anticancer drug targeting the human choline kinase alpha, an enzyme involved in increased lipid metabolism of cancer cells.
    Lacal JC; Campos JM
    Mol Cancer Ther; 2015 Jan; 14(1):31-9. PubMed ID: 25487918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined 5-FU and ChoKα inhibitors as a new alternative therapy of colorectal cancer: evidence in human tumor-derived cell lines and mouse xenografts.
    de la Cueva A; Ramírez de Molina A; Alvarez-Ayerza N; Ramos MA; Cebrián A; Del Pulgar TG; Lacal JC
    PLoS One; 2013; 8(6):e64961. PubMed ID: 23762272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acid ceramidase as a chemotherapeutic target to overcome resistance to the antitumoral effect of choline kinase α inhibition.
    Ramírez de Molina A; de la Cueva A; Machado-Pinilla R; Rodriguez-Fanjul V; Gomez del Pulgar T; Cebrian A; Perona R; Lacal JC
    Curr Cancer Drug Targets; 2012 Jul; 12(6):617-24. PubMed ID: 22515519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological activity of new bispyridinium salts of 4,4'-bispyridyl-5,5'-perfluoroalkyl-2,2'-bisoxazoles.
    Martín-Cantalejo Y; Sáez B; Monterde MI; Murillo MT; Braña MF
    Eur J Med Chem; 2011 Nov; 46(11):5662-7. PubMed ID: 21996467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel 4,4'-bispyridyl-5,5'-perfluoroalkyl-2,2'-bisoxazol with antitumoral activity via cell cycle arrest and induction of apoptosis.
    Báñez-Coronel M; Rodríguez-González A; Martín-Cantalejo Y; Sáez B; Soto J; Villa MJ; Braña MF; Lacal JC
    Int J Oncol; 2004 Oct; 25(4):1097-103. PubMed ID: 15375561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel 4-amino bis-pyridinium and bis-quinolinium derivatives as choline kinase inhibitors with antiproliferative activity against the human breast cancer SKBR-3 cell line.
    Gómez-Pérez V; McSorley T; See Too WC; Konrad M; Campos JM
    ChemMedChem; 2012 Apr; 7(4):663-9. PubMed ID: 22278967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Small Molecule Inhibitors of Choline Kinase Identified by Fragment-Based Drug Discovery.
    Zech SG; Kohlmann A; Zhou T; Li F; Squillace RM; Parillon LE; Greenfield MT; Miller DP; Qi J; Thomas RM; Wang Y; Xu Y; Miret JJ; Shakespeare WC; Zhu X; Dalgarno DC
    J Med Chem; 2016 Jan; 59(2):671-86. PubMed ID: 26700752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choline kinase alpha depletion selectively kills tumoral cells.
    Bañez-Coronel M; Ramírez de Molina A; Rodríguez-González A; Sarmentero J; Ramos MA; García-Cabezas MA; García-Oroz L; Lacal JC
    Curr Cancer Drug Targets; 2008 Dec; 8(8):709-19. PubMed ID: 19075594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo antitumor activity of choline kinase inhibitors: a novel target for anticancer drug discovery.
    Hernández-Alcoceba R; Fernández F; Lacal JC
    Cancer Res; 1999 Jul; 59(13):3112-8. PubMed ID: 10397253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New non-symmetrical choline kinase inhibitors.
    Schiaffino-Ortega S; López-Cara LC; Ríos-Marco P; Carrasco-Jimenez MP; Gallo MA; Espinosa A; Marco C; Entrena A
    Bioorg Med Chem; 2013 Nov; 21(22):7146-54. PubMed ID: 24080101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and biological evaluation of NAD(P)H: Quinone oxidoreductase (NQO1)-targeted oridonin prodrugs possessing indolequinone moiety for hypoxia-selective activation.
    Xu S; Yao H; Pei L; Hu M; Li D; Qiu Y; Wang G; Wu L; Yao H; Zhu Z; Xu J
    Eur J Med Chem; 2017 May; 132():310-321. PubMed ID: 28395199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QSAR-derived choline kinase inhibitors: how rational can antiproliferative drug design be?
    Campos J; Núñez MC; Conejo-García A; Sánchez-Martín RM; Hernández-Alcoceba R; Rodríguez-González A; Lacal JC; Gallo MA; Espinosa A
    Curr Med Chem; 2003 Jul; 10(13):1095-112. PubMed ID: 12678804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, biological evaluation, in silico modeling and crystallization of novel small monocationic molecules with potent antiproliferative activity by dual mechanism.
    Serrán-Aguilera L; Mariotto E; Rubbini G; Castro Navas FF; Marco C; Carrasco-Jiménez MP; Ballarotto M; Macchiarulo A; Hurtado-Guerrero R; Viola G; Lopez-Cara LC
    Eur J Med Chem; 2020 Dec; 207():112797. PubMed ID: 32977218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a Unique Inhibitor-Binding Site on Choline Kinase α.
    Kall SL; Delikatny EJ; Lavie A
    Biochemistry; 2018 Feb; 57(8):1316-1325. PubMed ID: 29389115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of new triterpenic monomers and dimers as potential antiproliferative agents and their molecular docking studies.
    Saeed A; Hussain H; Shamraiz U; Rehman NU; Khan HY; Badshah A; Heller L; Csuk R; Ali M; Khan A; Al-Harrasi A
    Eur J Med Chem; 2018 Jan; 143():948-957. PubMed ID: 29232585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro antiproliferative effect of novel quinoline-based potential anticancer agents.
    Arafa RK; Hegazy GH; Piazza GA; Abadi AH
    Eur J Med Chem; 2013 May; 63():826-32. PubMed ID: 23584545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (Q)SAR studies to design new human choline kinase inhibitors as antiproliferative drugs.
    Campos JM; Sánchez-Martín RM; Conejo-García A; Entrena A; Gallo MA; Espinosa A
    Curr Med Chem; 2006; 13(11):1231-48. PubMed ID: 16712467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symmetrical bis-quinolinium compounds: new human choline kinase inhibitors with antiproliferative activity against the HT-29 cell line.
    Sánchez-Martín R; Campos JM; Conejo-García A; Cruz-López O; Báñez-Coronel M; Rodríguez-González A; Gallo MA; Lacal JC; Espinosa A
    J Med Chem; 2005 May; 48(9):3354-63. PubMed ID: 15857141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models.
    Al-Saffar NM; Troy H; Ramírez de Molina A; Jackson LE; Madhu B; Griffiths JR; Leach MO; Workman P; Lacal JC; Judson IR; Chung YL
    Cancer Res; 2006 Jan; 66(1):427-34. PubMed ID: 16397258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.